Research indicates the GIP component might also greatly enhance the gastrointestinal tolerability on the medication, perhaps mitigating a few of the side effects usually involved with GLP-1 receptor agonists19.It's well worth noting that titration—setting up with a reduced dose and gradually raising—might help lower these Unwanted side effects.